Down-Regulation of Bcl-2 Protein Sensitizes NCI-H460 Cells to Radiotherapy-Induced Apoptosis

被引:0
作者
Dongmei He Yuan Zhang Gexiu Liu Institute of Hematology
机构
关键词
Bcl-2; antisense oligonucleotide; H460; cells; radiation; apopto-sis;
D O I
暂无
中图分类号
R730.5 [肿瘤治疗学];
学科分类号
100214 ;
摘要
OBJECTIVE To determine whether Bcl -2 protein down -regulation can render NCI -460 cells more susceptible to gamma radiation -induced apoptosis by treatment with antisense oligonucleotide (ASODN) against the coding region of Bcl-2 mRNA. METHODS Cell survival was determined using the trypan blue dye exclusion. Expression of the Bcl-2 protein was assayed using immunofluo-rescence labeling with fluoresce isothiocyanate. Apoptosis was determined by Giemsa staining and flow cytomertry. RESULTS It was found that Bcl-2 ASODN combined with radiation significantly reduced the number of viable cells (P<0.05). There was no difference in cell survival between a nonsense oligodeoxynucleotide/radia-tion combination and cells treated with radiation alone. Bcl -2 ASODN combined with radiation significantly inhibited expression of the Bcl -2 protein in the NCI-H460 cells (P<0.05). Using Giemsa staining, cells treated with Bcl -2 ASODN combined with radiation at 72 h displayed classic apoptotic changes. Apoptotic rates of the NCI-H460 cells treated with Bcl-2 ASODN combined with radiation significantly increased (P< 0.05), compared with either a nonsense oligodeoxynucleotide/radiation combination or radiation-treatment cells alone. CONCLUSION ASODN against the coding region of Bcl-2 mRNA increases radiation-induced apoptosis in NCI-H460 cells.
引用
收藏
页码:110 / 113
页数:4
相关论文
共 10 条
  • [1] Lei XY,Zhang H,He DM.Bcl-2 Antisense oligodeoxy-nucleotide enhances araninosyl cytosine-induced apoptosis in primary acute leukemia, chronic myeloid leukemia cells. Chinese journal of Cancer . 2002
  • [2] Nguyen LN,Munshi A,Hobbs ML,et al.Paclitaxel restores radiation-induced apoptosis in a Bcl-2-expressing, radiation-resistant lymphoma cell line. International Journal of Radiation Oncology Biology Physics . 2001
  • [3] Miyashita T,Reed JC.Bcl -2 oncoprotein blocks chemotherapy -induced apoptosis in a human leukemia cell line. Blood . 1993
  • [4] van de Donk NW,Kamphuis MM,van Dijk M,et al.Chemosensitization of myeloma plasma cells by an anti-sense-mediated downregulation of Bcl -2 protein. Leukemia . 2003
  • [5] Mryashita T and Reed JC.Bcl-2 gene transfer increases relative resistance of s49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by gluco-corticoids and multiple chemotherapeutic drugs. Cancer Research . 1992
  • [6] Chanan-Khan A.Bcl-2 antisense therapy in B-cell malignancies. Blood Reviews . 2005
  • [7] Tolcher AW,Chi K,Kuhn J,et al.A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer. Clinical Cancer Research . 2005
  • [8] Fisher TC,Milner AE,Gregory CD,et al.Bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thynidylate stress is independent of classical resistance pathways. Cancer Research . 1993
  • [9] Waters JS,Webb A,Cunningham D,et al.Phase I clinical and pharmacokinetic study of Bcl -2 antisense oligonu-cleotide therapy in patients with non -Hodgkin’s lym-phoma. Journal of Clinical Oncology . 2000
  • [10] Bloem A,Lockhorst H.Bcl-2 antisense therapy in multiple myeloma. Pathologie Biologie . 1999